Breaking

After Putin calls for three-day ceasefire, Trump reiterates demand for permanent Ukraine truce
Israeli security chief says he’ll step down June 15, facing pressure from Netanyahu
Gangs attack another town in Haiti’s central region, killing an 11-year-old child and three others
Canada’s Liberals projected to win election overshadowed by Trump’s threats
First batch of Hong Kong democrats freed after four years’ prison for subversion
Convicted Italian cardinal pulls out of conclave to choose new pope
‘Mushroom murder’ trial begins for woman accused of killing lunch guests in Australia
Restaurant fire kills 22 in northeast China’s Liaoning

Business
Investing
Stocks
World
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

What is the VIX Index?

4 Biggest Cybersecurity ETFs in 2025

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (213)
- Investing (718)
- Stocks (282)
- World (875)

Disclaimer: milkymoneyway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 milkymoneyway.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.